Scailyte Company
Scailyte has established a data-driven biomarker discovery platform that leverages unique expertise in single-cell data analysis and artificial intelligence. We are utilizing this platform to discover a new class of biomarkers, which are defined by the molecular profiles of disease-associated cells. This phenotypic approach to biomarker discovery is radically new and directly related to the biology of a disease, which maximizes the success rate for discovering sensitive and robust biomarkers.
.png)
.jpeg)
Technology:
Artificial Intelligence, Biotechnology, Health Diagnostics, Medical
Industry:
Data Processing, Clinical Development
Headquarters:
Basel, Basel-Stadt, Switzerland
Founded Date:
2017-06-19
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
6
Total Funding:
7548199
Estimated Revenue:
Less than $1M
Last Funding Date:
2022-01-10
Last Funding Type:
Series A
Register and Claim Ownership